22,306
Views
0
CrossRef citations to date
0
Altmetric
Review

Paracetamol (acetaminophen) overdose and hepatotoxicity: mechanism, treatment, prevention measures, and estimates of burden of disease

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 297-317 | Received 01 Feb 2023, Accepted 05 Jun 2023, Published online: 12 Jul 2023

References

  • Brune K, Renner B, Tiegs G. Acetaminophen/Paracetamol: a history of errors, failures and false decisions. Eur J Pain. 2015;19(7):953–965. doi: 10.1002/ejp.621
  • WHO model list of essential medicines - 22nd list, 2021. Geneva (Switzerland): World Health Organization; 2021.
  • Paracetamol [Internet]. Adelaide (Australia): Australian Medicines Handbook Pty Ltd; 2022 [cited 2022 Aug 16]. Available from: https://amhonline-amh-net-au/chapters/analgesics/drugs-pain-relief/non-opioid-analgesics/paracetamol
  • Acheampong P, Thomas SH. Determinants of hepatotoxicity after repeated supratherapeutic paracetamol ingestion: systematic review of reported cases. Br J Clin Pharmacol. 2016;82(4):923–931. doi: 10.1111/bcp.13028
  • Larson AM, Polson J, Fontana RJ, et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology. 2005;42(6):1364–1372. doi: 10.1002/hep.20948
  • Schiødt FV, Atillasoy E, Shakil AO, et al. Etiology and outcome for 295 patients with acute liver failure in the united states. Liver Transpl Surg. 1999;5(1):29–34. doi: 10.1002/lt.500050102
  • Bernal W, Wendon J. Acute liver failure; clinical features and management. Eur J Ganstroenterol Hepatol. 1999;11(9):977–984. doi: 10.1097/00042737-199909000-00005
  • Wei G, Bergquist A, Broomé U, et al. Acute liver failure in Sweden: etiology and outcome. J Intern Med. 2007;262(3):393–401. doi: 10.1111/j.1365-2796.2007.01818.x
  • Ostapowicz G, Fontana RJ, Schiødt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002;137(12):947–954. doi: 10.7326/0003-4819-137-12-200212170-00007
  • Bunchorntavakul C, Reddy KR. Acetaminophen-related hepatotoxicity. Clin Liver Dis. 2013;17(4):587–607. doi: 10.1016/j.cld.2013.07.005
  • Gulmez SE, Larrey D, Pageaux GP, et al. Liver transplant associated with paracetamol overdose: results from the seven-country SALT study. Br J Clin Pharmacol. 2015;80(3):599–606. doi: 10.1111/bcp.12635
  • Cahn A, Hepp P. Das Antifebrin, ein neues Fiebermittel. Centralbl Klin Med. 1886;7:561–564. German.
  • Mallet C, Eschalier A. Landmark papers in pain: seminal papers in pain with expert commentaries. Oxford (United Kingdom): Oxford University Press. Chapter 4, The rediscovery of paracetamol;2018. p. 12–16. doi: 10.1093/med/9780198834359.003.0004
  • Aronoff DM. Aspirin and Reyes syndrome: discovery of aspirin and paracetamol. Drug Saf. 2002;25(10):751. doi: 10.2165/00002018-200225100-00007
  • von Mering J. Beiträge zur Kenntnis der Antipyretica. Ther Monatsch. 1893;7:577–587. German.
  • Brodie BB, Axelrod J. The fate of acetophenetidin (phenacetin) in man and methods for the estimation of acetophenetidin and its metabolites in biological material. J Pharmacol Exp Ther. 1949;97(1):58–67.
  • Anderson BJ. Paracetamol (Acetaminophen): mechanisms of action. Pediatr Anesth. 2008;18(10):915–921. doi: 10.1111/j.1460-9592.2008.02764.x
  • Graham GG, Davies MJ, Day RO, et al. The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. Inflammopharmacology. 2013;21(3):201–232. doi: 10.1007/s10787-013-0172-x
  • Abdel Shaheed C, Ferreira GE, Dmitritchenko A, et al. The efficacy and safety of paracetamol for pain relief: an overview of systematic reviews. Med J Aust. 2021;214(7):324–331. doi: 10.5694/mja2.50992
  • Agrawal S, Khazaeni B. Acetaminophen Toxicity. Florida (United States of America): StatPearls Publishing; 2022.
  • Hodgman MJ, Garrard AR. A review of acetaminophen poisoning. Crit Care Clin. 2012;28(4):499–516. doi: 10.1016/j.ccc.2012.07.006
  • Leeming MG, Gamon LF, Wille U, et al. What are the potential sites of protein arylation by N-Acetyl-p-benzoquinone Imine (NAPQI)? Chem Res Toxicol. 2015;28(11):2224–2233. doi: 10.1021/acs.chemrestox.5b00373
  • Hinson JA, Roberts DW, James LP. Mechanisms of acetaminophen-induced liver necrosis. Handb Exp Pharmacol. 2010;196:369–405.
  • Ramachandran A, Jaeschke H. A mitochondrial journey through acetaminophen hepatotoxicity. Food Chem Toxicol. 2020;140:111282. doi: 10.1016/j.fct.2020.111282
  • Ramachandran A, Jaeschke H. Acetaminophen hepatotoxicity: a mitochondrial perspective. Advances in Pharmacology Volume 85. Academic Press;2019; p. 195–219. doi: 10.1016/bs.apha.2019.01.007
  • Moles A, Torres S, Baulies A, et al. Mitochondrial–Lysosomal axis in acetaminophen hepatotoxicity. Front Pharmacol. 2018;9:453. doi: 10.3389/fphar.2018.00453
  • Jaeschke H, Duan L, Nguyen NT, et al. Mitochondrial damage and biogenesis in acetaminophen-induced liver injury. Liver Res. 2019;3(3–4):150–156. doi: 10.1016/j.livres.2019.10.002
  • Saccomano SJ. Acute acetaminophen toxicity in adults. Nurse Pract. 2019;44(11):42–47. doi: 10.1097/01.NPR.0000586020.15798.c6
  • Green JL, Heard KJ, Reynolds KM, et al. Oral and intravenous acetylcysteine for treatment of acetaminophen toxicity: a systematic review and meta-analysis. West J Emerg Med. 2013;14(3):218–226. doi: 10.5811/westjem.2012.4.6885
  • Buckley N, Calear A, Cairns R, et al. Independent expert report on the risks of intentional self-poisoning with paracetamol. Canberra (Australia): Department of Health and Aged Care (Therapeutic Goods Administration); 2022.
  • Waring WS, Jamie H, Leggett GE. Delayed onset of acute renal failure after significant paracetamol overdose: a case series. Hum Exp Toxicol. 2010;29(1):63–68. doi: 10.1177/0960327109350799
  • Eguia L, Materson BJ. Acetaminophen-related acute renal failure without fulminant liver failure. Pharmacotherapy. 1997;17(2):363–370.
  • Loh CS, Ponampalam R. Nephrotoxicity associated with acute paracetamol overdose: a case report and review of the literature. Hong Kong J Of Emerg Med. 2006;13(2):105–110. doi: 10.1177/102490790601300202
  • Hart SGE, Beierschmitt WP, Wyand DS, et al. Acetaminophen nephrotoxicity in CD-1 Mice: i. evidence of a role for in situ activation in selective covalent binding and toxicity. Toxicol Appl Pharmacol. 1994;126(2):267–275. doi: 10.1006/taap.1994.1116
  • Flanagan RJ, Mant TGK. Coma and metabolic acidosis early in severe acute paracetamol poisoning. Hum Toxicol. 1986;5(3):179–182. doi: 10.1177/096032718600500305
  • Roth B, Woo O, Blanc P. Early metabolic acidosis and coma after acetaminophen ingestion. Ann Emerg Med. 1999;33(4):452–456. doi: 10.1016/S0196-0644(99)70312-4
  • Wiegand TJ, Margaretten M, Olson KR. Massive acetaminophen ingestion with early metabolic acidosis and coma: treatment with IV NAC and continuous venovenous hemodiafiltration. Clin Toxicol (Phila). 2010;48(2):156–159. doi: 10.3109/15563650903524142
  • Vliegenthart ADB, Kimmitt RA, Seymour JH, et al. Circulating acetaminophen metabolites are toxicokinetic biomarkers of acute liver injury. Clin Pharmacol Ther. 2017;101(4):531–540. doi: 10.1002/cpt.541
  • Chiew AL, Isbister GK, Kirby KA, et al. Massive paracetamol overdose: an observational study of the effect of activated charcoal and increased acetylcysteine dose (ATOM-2). Clin Toxicol (Phila). 2017;55(10):1055–1065. doi: 10.1080/15563650.2017.1334915.
  • Downs JW, Cumpston KL, Kershner EK, et al. Clinical outcome of massive acetaminophen overdose treated with standard-dose N-acetylcysteine. Clin Toxicol (Phila). 2021;59(10):932–936. doi: 10.1080/15563650.2021.1887493
  • Lewis JC, Lim M, Lai L, et al. Evaluation of N-acetylcysteine dose for the treatment of massive acetaminophen ingestion. Clin Toxicol (Phila). 2022;60(4):507–513. doi: 10.1080/15563650.2021.1984503
  • Gloor Y, Schvartz D, Samer CF. Old problem, new solutions: biomarker discovery for acetaminophen liver toxicity. Expert Opin Drug Metab Toxicol. 2019;15(8):659–669. doi: 10.1080/17425255.2019.1642323
  • The Flockhart Cytochrome P450 Drug-Drug Interaction Table [Internet]. Indiana (United States of America): Division of Clinical Pharmacology, Indiana University School of Medicine; [updated 2021, cited 2022 Oct 4]. Available from: https://drug-interactions.medicine.iu.edu/MainTable.aspx
  • Nguyen GC, Sam J, Thuluvath PJ. Hepatitis C is a predictor of acute liver injury among hospitalizations for acetaminophen overdose in the United States: a nationwide analysis. Hepatology. 2008;48(4):1336–1341. doi: 10.1002/hep.22536
  • Whitcomb DC, Block GD. Association of Acetaminophen Hepatotoxicity with Fasting and Ethanol Use. JAMA. 1994;272(23):1845–1850. doi: 10.1001/jama.1994.03520230055038
  • Seeff LB, Cuccherini BA, Zimmerman HJ, et al. Acetaminophen Hepatotoxicity in Alcoholics. Ann Intern Med. 1986;104(3):399–404. doi: 10.7326/0003-4819-104-3-399
  • Peterson FJ, Holloway DE, Erickson RR, et al. Ethanol induction of acetaminophen toxicity and metabolism. Life Sci. 1980;27(18):1705–1711. doi: 10.1016/0024-3205(80)90646-3
  • Prescott LF. Paracetamol, alcohol and the liver. Br J Clin Pharmacol. 2000;49(4):291–301. doi: 10.1046/j.1365-2125.2000.00167.x
  • Bray GP, Mowat C, Muir DF, et al. The Effect of Chronic Alcohol Intake on Prognosis and Outcome in Paracetamol Overdose. Hum Exp Toxicol. 1991;10(6):435–438. doi: 10.1177/096032719101000612
  • Waring WS, Stephen AF, Malkowska AM, et al. Acute Ethanol Coingestion Confers a Lower Risk of Hepatotoxicity after Deliberate Acetaminophen Overdose. Acad Emerg Med. 2008;15(1):54–58. doi: 10.1111/j.1553-2712.2007.00019.x
  • Graudins A, Chiew A, Chan B. Overdose with modified-release paracetamol results in delayed and prolonged absorption of paracetamol. Intern Med J. 2010;40(1):72–76. doi: 10.1111/j.1445-5994.2009.02096.x
  • Li J, Chiew AL, Isbister GK, et al. Population pharmacokinetics of immediate-release and modified-release paracetamol and its major metabolites in a supratherapeutic dosing study. Clin Toxicol (Phila). 2022;60(1):25–32. doi: 10.1080/15563650.2021.1928163
  • Spyker DA, Dart RC, Yip L, et al. Population pharmacokinetic analysis of acetaminophen overdose with immediate release, extended release and modified release formulations. Clin Toxicol (Phila). 2022;60(10):1113–1121. doi: 10.1080/15563650.2022.2114361
  • Chiew AL, Isbister GK, Page CB, et al. Modified release paracetamol overdose: a prospective observational study (ATOM-3). Clin Toxicol (Phila). 2018;56(9):810–819. doi: 10.1080/15563650.2018.1439950.
  • Michienzi A, Tobarran N, Hieger MA. Extended Release Acetaminophen Overdose with Delayed Peak Concentrations. Am J Ther. 2022;29(6):e655–e656. doi: 10.1097/MJT.0000000000001329
  • Hoegberg LCG, Refsgaard F, Pedersen SH, et al. Potential pharmacobezoar formation of large size extended-release tablets and their dissolution – an in vitro study. Clin Toxicol (Phila). 2019;57(4):271–281. doi: 10.1080/15563650.2018.1513138
  • Li YK, Lam KF, Wong CLW, et al. In vitro study of pharmacobezoar formation in simulated acetaminophen overdose. Clin Toxicol (Phila). 2020;58(9):900–906. doi: 10.1080/15563650.2019.1705971
  • Cairns R, Brown JA, Wylie CE, et al. Paracetamol poisoning‐related hospital admissions and deaths in Australia, 2004–2017. Med J Aust. 2019;211(5):218–223. doi: 10.5694/mja2.50296
  • Dart RC, Green JL, Bogdan GM. The Safety Profile of Sustained Release Paracetamol During Therapeutic Use and Following Overdose. Drug Saf. 2005;28(11):1045–1056. doi: 10.2165/00002018-200528110-00005
  • Chiew AL, Buckley NA. Comment on: “population pharmacokinetic analysis of acetaminophen overdose with immediate release, extended release and modified release formulations”. Clin Toxicol (Phila). 2023;61(2):139–140. doi: 10.1080/15563650.2022.2135519
  • Vogel J, Heard KJ, Carlson C, et al. Dental pain as a risk factor for accidental acetaminophen overdose: a case-control study. Am J Emerg Med. 2011;29(9):1125–1129. doi: 10.1016/j.ajem.2010.08.006
  • Schiødt FV, Rochling FA, Casey DL, et al. Acetaminophen Toxicity in an Urban County Hospital. New Engl J Med. 1997;337(16):1112–1118. doi: 10.1056/NEJM199710163371602
  • Gyamlani GG, Parikh CR. Acetaminophen toxicity: suicidal vs accidental. Crit Care. 2002;6(2):155–159. doi: 10.1186/cc1475
  • Myers RP, Shaheen AAM, Li B, et al. Impact of Liver Disease, Alcohol Abuse, and Unintentional Ingestions on the Outcomes of Acetaminophen Overdose. Clin Gastroenterol Hepatol. 2008;6(8):918–925. doi: 10.1016/j.cgh.2008.02.053
  • Egan H, Isbister GK, Robinson J, et al. Retrospective evaluation of repeated supratherapeutic ingestion (RSTI) of paracetamol. Clin Toxicol (Phila). 2019;57(8):703–711. doi: 10.1080/15563650.2018.1547829
  • Alhelail MA, Hoppe JA, Rhyee SH, et al. Clinical course of repeated supratherapeutic ingestion of acetaminophen. Clin Toxicol (Phila). 2011;49(2):108–112. doi: 10.3109/15563650.2011.554839
  • Craig DGN, Bates CM, Davidson JS, et al. Staggered overdose pattern and delay to hospital presentation are associated with adverse outcomes following paracetamol-induced hepatotoxicity. Br J Clin Pharmacol. 2012;73(2):285–294. doi: 10.1111/j.1365-2125.2011.04067.x
  • Myers RP, Shaheen AAM. Hepatitis C, alcohol abuse, and unintentional overdoses are risk factors for acetaminophen-related hepatotoxicity. Hepatology. 2009;49(4):1399–1400. doi: 10.1002/hep.22798
  • Rutherford A, Davern T, Hay JE, et al. Influence of High Body Mass Index on Outcome in Acute Liver Failure. Clin Gastroenterol Hepatol. 2006;4(12):1544–1549. doi: 10.1016/j.cgh.2006.07.014
  • Radosevich JJ, Patanwala AE, Erstad BL. Hepatotoxicity in Obese versus Nonobese Patients with Acetaminophen Poisoning Who are Treated with Intravenous N-Acetylcysteine. Am J Ther. 2016;23(3):e714–e719. doi: 10.1097/01.mjt.0000434043.62372.00
  • Michaut A, Moreau C, Robin MA, et al. Acetaminophen-induced liver injury in obesity and nonalcoholic fatty liver disease. Liver Int. 2014;34(7):e171–e179. doi: 10.1111/liv.12514
  • Heruth DP, Shortt K, Zhang N, et al. Genetic Association of Single Nucleotide Polymorphisms with Acetaminophen-Induced Hepatotoxicity. J Pharmacol Exp Ther. 2018;367(1):95–100. doi: 10.1124/jpet.118.248583
  • Monte AA, Arriaga Mackenzie I, Pattee J, et al. Genetic variants associated with ALT elevation from therapeutic acetaminophen. Clin Toxicol (Phila). 2022;60(11):1198–1204. doi: 10.1080/15563650.2022.2117053
  • Chiew AL, Reith D, Pomerleau A, et al. Updated guidelines for the management of paracetamol poisoning in Australia and New Zealand. Med J Aust. 2020;212(4):175–183. doi: 10.5694/mja2.50428
  • Wong A, Graudins A. Risk prediction of hepatotoxicity in paracetamol poisoning. Clin Toxicol (Phila). 2017;55(8):879–892. doi: 10.1080/15563650.2017.1317349
  • Dear JW, Antoine DJ. Stratification of paracetamol overdose patients using new toxicity biomarkers: current candidates and future challenges. Expert Rev Clin Pharmacol. 2014;7(2):181–189. doi: 10.1586/17512433.2014.880650
  • Bateman DN, Carroll R, Pettie J, et al. Effect of the UK’s revised paracetamol poisoning management guidelines on admissions, adverse reactions and costs of treatment. Br J Clin Pharmacol. 2014;78(3):610–618. doi: 10.1111/bcp.12362
  • Gosselin S, Hoffman RS, Juurlink DN, et al. Treating acetaminophen overdose: thresholds, costs and uncertainties. Clin Toxicol (Phila). 2013;51(3):130–133. doi: 10.3109/15563650.2013.775292
  • Bateman DN, Dear JW, Carroll R, et al. Impact of reducing the threshold for acetylcysteine treatment in acute paracetamol poisoning: the recent United Kingdom experience. Clin Toxicol (Phila). 2014;52(8):868–872. doi: 10.3109/15563650.2014.954125
  • Schmidt LE, Dalhoff K. Risk factors in the development of adverse reactions to N-acetylcysteine in patients with paracetamol poisoning. Br J Clin Pharm. 2001;51(1):87–91. doi: 10.1046/j.1365-2125.2001.01305.x
  • Watkins PB, Kaplowitz N, Slattery JT, et al. Aminotransferase Elevations in Healthy Adults Receiving 4 Grams of Acetaminophen Daily: a Randomized Controlled Trial. JAMA. 2006;296(1):87–93. doi: 10.1001/jama.296.1.87
  • Chiew AL, James LP, Isbister GK, et al. Early acetaminophen-protein adducts predict hepatotoxicity following overdose (ATOM-5). J Hepatol. 2020;72(3):450–462. doi: 10.1016/j.jhep.2019.10.030
  • Green TJ, Sivilotti MLA, Langmann C, et al. When do the aminotransferases rise after acute acetaminophen overdose? Clin Toxicol (Phila). 2010;48(8):787–792. doi: 10.3109/15563650.2010.523828
  • Curtis RM, Sivilotti MLA. A descriptive analysis of aspartate and alanine aminotransferase rise and fall following acetaminophen overdose. Clin Toxicol (Phila). 2015;53(9):849–855. doi: 10.3109/15563650.2015.1077968
  • Lindena J, Sommerfeld U, Höpfel C, et al. Catalytic Enzyme Activity Concentration in Tissues of Man, Dog, Rabbit, Guinea Pig, Rat and Mouse. Approach to a Quantitative Diagnostic Enzymology, III. Communication. J Clin Chem Clin Biochem. 1986;24(1):35–47. doi: 10.1515/cclm.1986.24.1.35
  • Antoine DJ, Dear JW, Lewis PS, et al. Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital. Hepatology. 2013;58(2):777–787. doi: 10.1002/hep.26294.
  • Sivilotti MLA, Green TJ, Langmann C, et al. Multiplying the serum aminotransferase by the acetaminophen concentration to predict toxicity following overdose. Clin Toxicol (Phila). 2010;48(8):793–799. doi: 10.3109/15563650.2010.523829
  • Wong A, Sivilotti MLA, Dargan PI, et al. External validation of the paracetamol-aminotransferase multiplication product to predict hepatotoxicity from paracetamol overdose. Clin Toxicol (Phila). 2015;53(8):807–814. doi: 10.3109/15563650.2015.1066507.
  • Wong A, Sivilotti MLA, Graudins A. Accuracy of the paracetamol-aminotransferase multiplication product to predict hepatotoxicity in modified-release paracetamol overdose. Clin Toxicol (Phila). 2017;55(5):346–351. doi: 10.1080/15563650.2017.1290253
  • Yau CE, Chen H, Lim BPY, et al. Performance of the paracetamol-aminotransferase multiplication product in risk stratification after paracetamol (acetaminophen) poisoning: a systematic review and meta-analysis. Clin Toxicol (Phila). 2023;61(1):1–11. doi: 10.1080/15563650.2022.2152350
  • Owens KH, Medlicott NJ, Zacharias M, et al. Population pharmacokinetic–pharmacodynamic modelling to describe the effects of paracetamol and N-acetylcysteine on the international normalized ratio. Clin Exp Pharmacol Physiol. 2015;42(1):102–108. doi: 10.1111/1440-1681.12327
  • Davern TJ II, James LP, Hinson JA, et al. Measurement of serum acetaminophen–protein adducts in patients with acute liver failure. Gastroenterology. 2006;130(3):687–694. doi: 10.1053/j.gastro.2006.01.033
  • James LP, Letzig L, Simpson PM, et al. Pharmacokinetics of acetaminophen-protein adducts in adults with acetaminophen overdose and acute liver failure. Drug Metab Dispos. 2009;37(8):1779–1784. doi: 10.1124/dmd.108.026195
  • Chiew AL, Gluud C, Brok J, et al. Interventions for paracetamol (acetaminophen) overdose. Cochrane Database Syst Rev. 2018;(2):CD003328. doi: 10.1002/14651858.CD003328.pub3
  • Buckley NA, Buckley N, Whyte IM, et al. Activated charcoal reduces the need for N-Acetylcysteine treatment after acetaminophen (paracetamol) overdose. J Toxicol Clin Toxicol. 1999;37(6):753–757. doi: 10.1081/CLT-100102452
  • Lauterburg BH, Corcoran GB, Mitchell JR. Mechanism of Action of N-Acetylcysteine in the Protection Against the Hepatotoxicity of Acetaminophen in Rats in vivo. J Clin Invest. 1983;71(4):980–991. doi: 10.1172/JCI110853
  • Tenório MCdS, Graciliano NG, Moura FA, et al. N-Acetylcysteine (NAC): impacts on human health. Antioxidants. 2021;10(6):967. doi: 10.3390/antiox10060967
  • Saito C, Zwingmann C, Jaeschke H. Novel mechanisms of protection against acetaminophen hepatotoxicity in mice by glutathione and N‐acetylcysteine. Hepatology. 2010;51(1):246–254. doi: 10.1002/hep.23267
  • Prescott LF, Illingworth RN, Critchley JA, et al. Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning. Br Med J. 1979;2(6198):1097–1100. doi: 10.1136/bmj.2.6198.1097
  • Clark R, Borirakchanyavat V, Davidson AR, et al. Hepatic damage and death from overdose of paracetamol. Lancet. 1973;301(7794):66–70. doi: 10.1016/S0140-6736(73)90466-2
  • Bateman DN, Dear JW. Acetylcysteine in paracetamol poisoning: a perspective of 45 years of use. Toxicol Res (Camb). 2019;8(4):489–498. doi: 10.1039/C9TX00002J
  • Wong A, Graudins A. Simplification of the standard three-bag intravenous acetylcysteine regimen for paracetamol poisoning results in a lower incidence of adverse drug reactions. Clin Toxicol (Phila). 2016;54(2):115–119. doi: 10.3109/15563650.2015.1115055
  • McNulty R, Lim JME, Chandru P, et al. Fewer adverse effects with a modified two-bag acetylcysteine protocol in paracetamol overdose. Clin Toxicol (Phila). 2018;56(7):618–621. doi: 10.1080/15563650.2017.1408812
  • Pettie JM, Caparrotta TM, Hunter RW, et al. Safety and Efficacy of the SNAP 12-hour Acetylcysteine Regimen for the Treatment of Paracetamol Overdose. EClinicalMedicine. 2019;11:11–17.
  • Johnson MT, McCammon CA, Mullins ME, et al. Evaluation of a Simplified N-Acetylcysteine Dosing Regimen for the Treatment of Acetaminophen Toxicity. Ann Pharmacother. 2011;45(6):713–720. doi: 10.1345/aph.1P613
  • Wong A, Gunja N, McNulty R, et al. Analysis of an 8-hour acetylcysteine infusion protocol for repeated supratherapeutic ingestion (RSTI) of paracetamol. Clin Toxicol (Phila). 2018;56(3):199–203. doi: 10.1080/15563650.2017.1359620
  • Daly FFS, O’Malley GF, Heard K, et al. Prospective evaluation of repeated supratherapeutic acetaminophen (paracetamol) ingestion. Ann Emerg Med. 2004;44(4):393–398. doi: 10.1016/j.annemergmed.2004.05.005
  • Janković SM. Acetaminophen toxicity and overdose: current understanding and future directions for NAC dosing regimens. Expert Opin Drug Metab Toxicol. 2022;18(11):745–753. doi: 10.1080/17425255.2022.2151893
  • Prescott LF, Sutherland GR, Park J, et al. Cysteamine, Methionine, and Penicillamine in the Treatment of Paracetamol Poisoning. Lancet. 1976;308(7977):109–113. doi: 10.1016/S0140-6736(76)92842-7
  • Vale JA, Meredith TJ, Goulding R. Treatment of Acetaminophen Poisoning: the Use of Oral Methionine. Arch Intern Med. 1981;141(3):394–396. doi: 10.1001/archinte.1981.00340030126023
  • Mullins ME, Yeager LH, Freeman WE. Metabolic and mitochondrial treatments for severe paracetamol poisoning: a systematic review. Clin Toxicol (Phila). 2020;58(12):1284–1296. doi: 10.1080/15563650.2020.1798979
  • Dear JW. Fomepizole should not be used more liberally in paracetamol overdose. Br J Clin Pharmacol. 2023;89(2):599–601. doi: 10.1111/bcp.15596
  • Akakpo JY, Ramachandran A, Duan L, et al. Delayed Treatment with 4-Methylpyrazole Protects Against Acetaminophen Hepatotoxicity in Mice by Inhibition of c-Jun n-Terminal Kinase. Toxicol Sci. 2019;170(1):57–68. doi: 10.1093/toxsci/kfz077
  • Link SL, Rampon G, Osmon S, et al. Fomepizole as an adjunct in acetylcysteine treated acetaminophen overdose patients: a case series. Clin Toxicol (Phila). 2022;60(4):472–477. doi: 10.1080/15563650.2021.1996591
  • Filip AB, Berg SE, Mullins ME, et al. Fomepizole as an adjunctive therapy for acetaminophen poisoning: cases reported to the toxicology investigators consortium (ToxIC) database 2015–2020. Clin Toxicol (Phila). 2022;60(9):1006–1011. doi: 10.1080/15563650.2022.2070071.
  • Bateman DN, Dear JW, Eddleston M, et al. Comment on Fomepizole as an adjunct in acetylcysteine treated acetaminophen overdose patients: a case series. Clin Toxicol (Phila). 2022;60(5):666–667. doi: 10.1080/15563650.2021.2009849
  • Link SL, Rampon G, Osmon S, et al. Reply to Comments on Fomepizole as an adjunct in acetylcysteine treated acetaminophen overdose patients: a case series. Clin Toxicol (Phila). 2022;60(5):668–669. doi: 10.1080/15563650.2021.2016799
  • Agarwal R, MacMillan-Crow LA, Rafferty TM, et al. Acetaminophen-Induced Hepatotoxicity in Mice Occurs with Inhibition of Activity and Nitration of Mitochondrial Manganese Superoxide Dismutase. J Pharmacol Exp Ther. 2011;337(1):110–118. doi: 10.1124/jpet.110.176321
  • Morrison EE, Oatey K, Gallagher B, et al. Principal results of a randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with a 12 h regimen of N-acetylcysteine for paracetamol overdose (POP trial). EBioMedicine. 2019;46:423–430. doi: 10.1016/j.ebiom.2019.07.013
  • Akakpo JY, Ramachandran A, Jaeschke H. Novel strategies for the treatment of acetaminophen hepatotoxicity. Expert Opin Drug Metab Toxicol. 2020;16(11):1039–1050. doi: 10.1080/17425255.2020.1817896
  • Ding GKA, Buckley NA. Evidence and consequences of spectrum bias in studies of criteria for liver transplant in paracetamol hepatotoxicity. QJM. 2008;101(9):723–729. doi: 10.1093/qjmed/hcn077
  • O’Grady JG, Alexander GJM, Hayllar KM, et al. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989;97(2):439–445. doi: 10.1016/0016-5085(89)90081-4
  • O’Grady J. Timing and benefit of liver transplantation in acute liver failure. J Hepatol. 2014;60(3):663–670. doi: 10.1016/j.jhep.2013.10.024
  • 7 continents [Internet]. Worldometer; [cited 2023 Jan 5]. Available from: https://www.worldometers.info/geography/7-continents/
  • Gummin DD, Mowry JB, Spyker DA, et al. 2016 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 34th Annual Report. Clin Toxicol (Phila). 2017;55(10):1072–1254. doi: 10.1080/15563650.2017.1388087
  • Gummin DD, Mowry JB, Spyker DA, et al. 2017 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 35th Annual Report. Clin Toxicol (Phila). 2018;56(12):1213–1415. doi: 10.1080/15563650.2018.1533727
  • Gummin DD, Mowry JB, Spyker DA, et al. 2018 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 36th Annual Report. Clin Toxicol (Phila). 2019;57(12):1220–1413. doi: 10.1080/15563650.2019.1677022
  • Gummin DD, Mowry JB, Beuhler MC, et al. 2019 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 37th Annual Report. Clin Toxicol (Phila). 2020;58(12):1360–1541. doi: 10.1080/15563650.2020.1834219
  • Descamps AMK, Vandijck DM, Buylaert WA, et al. Characteristics and costs in adults with acute poisoning admitted to the emergency department of a university hospital in Belgium. PLoS ONE. 2019;14(10):e0223479. doi: 10.1371/journal.pone.0223479
  • Descamps AK, Vandijck D, Buylaert W, et al. Hospital referrals of patients with acute poisoning by the Belgian Poison Centre: analysis of characteristics, associated factors, compliance and costs. Emerg Med J. 2021;38(7):511–519. doi: 10.1136/emermed-2019-209202
  • Mbongwe B, Moinami J, Masupe T, et al. Nature and sources of poisoning in patients admitted to a referral hospital in Gaborone, Botswana; findings and implications. Hosp Pract. 2020;48(2):100–107. doi: 10.1080/21548331.2020.1739415
  • Zhang Y, Yu B, Wang N, et al. Acute poisoning in Shenyang, China: a retrospective and descriptive study from 2012 to 2016. BMJ Open. 2018;8(8):e021881. doi: 10.1136/bmjopen-2018-021881
  • Andersen CU, Nielsen LP, Møller JM, et al. Acute drug poisonings leading to hospitalization. Basic Clin Pharmacol Toxicol. 2022;130(2):328–336. doi: 10.1111/bcpt.13688
  • Afandiyev I, Kobidze T, Kereselidze M, et al. СРАВНИТЕЛЬНАЯ СТРУКТУРА ОСТРЫХ ОТРАВЛЕНИЙ В ДВУХ СТОЛИЧНЫХ ГОРОДАХ РЕГИОНА ЮЖНОГО КАВКАЗА [The comparative structure of acute poisonings in two capital cities of the South Caucasus region]. Georgian Med News. 2019;287(2):105–110. Russian.
  • Gudjonsdottir GA, Thordardottir AM, Kristinsson J. Framskyggn rannsókn á eitrunum sem komu til meðferðar á bráðamóttökum Landspítala 2012 [A prospective study on acute poisonings presenting to the Emergency Department at Landspitali University Hospital in Iceland 2012]. Laeknabladid. 2017;103(6):275–280. Icelandic. doi: 10.17992/lbl.2017.06.140
  • Bentur Y, Lurie Y, Cahana A, et al. Poisoning in Israel: annual Report of the Israel Poison Information Center, 2017. Isr Med Assoc J. 2019;21(3):175–182.
  • Yehya A, Albals D, Issa R, et al. Retrospective assessment of acute poisoning incidents by pharmaceutical agents in Jordan: data from Pharmacy One™ Poison Call Center, 2014 to 2018-Part II. Pharmacol Res Perspect. 2020;8(2):e00583. doi: 10.1002/prp2.583
  • Hondebrink L, Rietjens SJ, Donker DW, et al. A quarter of admitted poisoned patients have a mild poisoning and require no treatment: an observational study. Eur J Intern Med. 2019;66:41–47. doi: 10.1016/j.ejim.2019.05.012
  • Liakoni E, Berger F, Klukowska-Rötzler J, et al. Characteristics of emergency department presentations requiring consultation of the national Poisons Information Centre. Swiss Med Wkly. 2019;149(5152):w20164. doi: 10.4414/smw.2019.20164
  • Sungur S, Bilge U, Acar N, et al. Retrospective evaluation of adult poisoning cases admitted to emergency department of a University Hospital in Turkey. Niger J Clin Pract. 2018;21(8):1023–1028. doi: 10.4103/njcp.njcp_291_17
  • Friedman N, Shoshani-Levy M, Brent J, et al. Fatalities in poisoned patients managed by medical toxicologists. Clin Toxicol (Phila). 2020;58(7):688–691. doi: 10.1080/15563650.2019.1672877
  • Beauchamp GA, Carey JL, Adams T, et al. Sex Differences in Poisonings Among Older Adults: an Analysis of the Toxicology Investigators Consortium (ToxIC) Registry, 2010 to 2016. Clin Ther. 2018;40(8):1366–1374.e8. doi: 10.1016/j.clinthera.2018.06.012
  • Farrugia LA, Rhyee SH, Calello DP, et al. The Toxicology Investigators Consortium Case Registry-the 2016 Experience. J Med Toxicol. 2017;13(3):203–226. doi: 10.1007/s13181-017-0627-3
  • Spyres MB, Farrugia LA, Kang AM, et al. The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report. J Med Toxicol. 2020;16(4):361–387. doi: 10.1007/s13181-020-00810-7
  • Leonard JB, Minhaj FS, Paterson E, et al. Exposures in pregnant patients reported to United States Poison Centers. Clin Toxicol (Phila). 2022;60(3):356–361. doi: 10.1080/15563650.2021.1968420
  • Babić Ž, Turk R. Izvješće Centra za kontrolu otrovanja za 2021 [Report of the Poison Control Centre for 2021]. Arh Hig Rada Toksikol. 2022;73(1): 88–93. Croatian.
  • Tygerberg Poison Information Centre Annual Report 2018. Cape Town (South Africa): Tygerberg Poison Information Centre.
  • Sebben VC, Lessa CAS. Relatório Anual 2020 [2020 Annual Report]. Porto Alegre (Brazil): Atendimentos do Centro de Informação Toxicológica do Rio Grande do Sul – CIT/RS; 2022. Portugese
  • Pan-Canadian Poison Centres 2020 Annual Report. Canada: Canadian Association of Poison Centres and Clinical Toxicology.
  • Bekaert E, De Cock P, De Leener K, et al. Jaarrapport 2021 [Annual Report 2021]. Brussels (Belgium): Antigifcentrum – Centre Antipoisons; 2022. Dutch.
  • Anhang zum EU Jahresbericht der VIZ 2014 [Annex to the EU Annual Report of the VIZ 2014]. Freiburg (Germany): Vergiftungs-Informations-Zentrale Freiburg; 2015. German.
  • Jahresbericht 2021 [Annual Report 2021]. Göttingen (Germany): Giftinformationszentrum-Nord der Länder Bremen, Hamburg, Niedersachsen und Schleswig-Holstein (GIZ-Nord); 2022. German.
  • Anhang zum Jahresbericht 2021 [Appendix to Annual Report 2021]. Zürich (Switzerland): Tox Info Suisse; 2022. German.
  • Jahresbericht 2021 [Annual Report 2021]. Bonn (Germany): Informationszentrale gegen Vergiftungen des Landes Nordrhein-Westfalen. German.
  • Boletim CIAV - Centro de Informação Antivenenos Dados Estatísticos 2021 [CIAV Bulletin – Antivenom Information Center Statistical Data 2021]. Lisbon (Portugal): CIAV - Centro de Informação Antivenenos. Portugese.
  • Annual Report 2018 Victorian Poisons Information Centre. Heidelberg (Australia): Victorian Poisons Information Centre.
  • Gummin DD, Mowry JB, Beuhler MC, et al. 2020 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 38th Annual Report. Clin Toxicol (Phila). 2021;59(12):1282–1501. doi: 10.1080/15563650.2021.1989785
  • Huynh A, Cairns R, Brown JA, et al. Patterns of poisoning exposure at different ages: the 2015 annual report of the Australian Poisons Information Centres. Med J Aust. 2018;209(2):74–79. doi: 10.5694/mja17.01063
  • Pillans PI, Page CB, Ilango S, et al. Self-poisoning by older Australians: a cohort study. Med J Aust. 2017;206(4):164–169. doi: 10.5694/mja16.00484
  • Magalhães AFA, Caldas ED. Two health information systems to characterize poisoning in Brazil-a descriptive study. J Public Health. 2019;41(1):203–211. doi: 10.1093/pubmed/fdy008
  • Kaur J, McFaull SR, Bang F. Trends in emergency department visits for acetaminophen-related poisonings: 2011-2019. Health Promot Chronic Dis Prev Can. 2020;40(4):130–133. doi: 10.24095/hpcdp.40.4.05
  • Klobučar I, Potočnjak I, Dumančić J, et al. Acute poisonings in Croatia: differences in epidemiology, associated comorbidities and final outcomes - a single-centre 15-year follow-up. Clin Toxicol (Phila). 2019;57(3):181–188. doi: 10.1080/15563650.2018.1506129
  • Eyasu M, Dida T, Worku Y, et al. Acute poisonings during pregnancy and in other non-pregnant women in emergency departments of four government hospitals, Addis Ababa, Ethiopia: 2010-2015. Trop Med Int Health. 2017;22(10):1350–1360. doi: 10.1111/tmi.12940
  • Salles J, Calonge J, Franchitto N, et al. Factors associated with hospitalization after self-poisoning in France: special focus on the impact of alcohol use disorder. BMC Psychiatry. 2018;18(1):287. doi: 10.1186/s12888-018-1854-0
  • Nair SJ, Sujatha C, Chettiar KPS, et al. Toxico-epidemiology of acute poisoning; an exploratory study from a tertiary care hospital in South India along with global comparisons and solutions. J Forensic Leg Med. 2021;83:102247. doi: 10.1016/j.jflm.2021.102247
  • Hitti E, El Zahran T, Hamade H, et al. Toxicological exposures reported to a telephonic consultation service at a tertiary care hospital in Lebanon. Clin Toxicol (Phila). 2020;58(9):886–892. doi: 10.1080/15563650.2019.1709643
  • Thapa S, Dawadi BR, Upreti AR. Acute Poisoning among Patients Presenting to the Emergency Department of a Tertiary Care Center: a Descriptive Cross-sectional Study. JNMA J Nepal Med Assoc. 2020;58(227):470–473. doi: 10.31729/jnma.4997
  • Kumpula EK, Shieffelbien LM, Pomerleau AC. Enquiries to the New Zealand National Poisons Centre in 2018. Emerg Med Australas. 2021;33(1):45–51. doi: 10.1111/1742-6723.13563
  • Kumpula EK, Richards R, Norris P, et al. A retrospective analysis of calls to the New Zealand National Poisons Centre regarding Pacific patients. N Z Med J. 2021;134(1528):26–34.
  • Khan M, Khurram M, Raza S. Gender based differences in patients of poisoning managed at a Medical Unit. J Pak Med Assoc. 2019;69(7):1025–1028.
  • Garczewski B, Wiśniewski M, Waldman W, et al. ZATRUCIA PARACETAMOLEM LECZONE W POMORSKIM CENTRUM TOKSYKOLOGII W LATACH 2010–2015 [Acetaminophen poisonings hospitalized at the Pomeranian Center of Toxicology in 2010-2015]. Med Pr. 2019;70(6):733–738. Polish. doi: 10.13075/mp.5893.00885
  • Scripcaru G, Mateus C, Nunes C. Adverse drug events-Analysis of a decade. A Portuguese case-study, from 2004 to 2013 using hospital database. PLoS ONE. 2017;12(6):e0178626. doi: 10.1371/journal.pone.0178626
  • Lionte C, Sorodoc V, Jaba E, et al. Development and validation of a risk-prediction nomogram for in-hospital mortality in adults poisoned with drugs and nonpharmaceutical agents: an observational study. Medicine. 2017;96(12):e6404. doi: 10.1097/MD.0000000000006404
  • Jung KY, Kim T, Hwang SY, et al. Availability of drug at convenient stores is not associated with an increased incidence of their poisoning. Pharmacoepidemiol Drug Saf. 2019;28(4):536–543. doi: 10.1002/pds.4760
  • Supervía Caparrós A, Pallàs Villaronga O, Clemente Rodríguez C, et al. Características diferenciales de las intoxicaciones en los pacientes ancianos atendidos en un servicio de urgencias [Characteristics of emergency poisoning cases in elderly versus younger patients]. Emergencias. 2017;29(5):335–338. Spanish.
  • Bowman C, Thornton S, Oller L, et al. Utilization of a poison control center by critical access hospitals-one state’s experience. Clin Toxicol (Phila). 2021;59(11):1015–1022. doi: 10.1080/15563650.2021.1903485
  • Exposisiones Humanas A Produtos Farmaceuticos/Medicamentos. Datos de mayor incidencia de reportes a CITUC, durante el primer semestre del 2018 [Human Exposures to Pharmaceutical Products/Medications. Data with the highest incidence of reports to CITUC, during the first semester of 2018]. Centro de Información Toxicológica de la Pontificia Universidad Católica de Chile. http://cituc.uc.cl/infografias/. Spanish.
  • Nugteren-van Lonkhuyzen JJ, van Velzen AG, Mulder-Spijkerboer HN, et al. Acute vergiftigingen bij mens en dier - NVIC Jaaroverzicht 2021. [Acute poisonings in humans and animals - NVIC Annual Review 2021]. Utrecht (Netherlands): Nationaal Vergiftigingen Informatie Centrum;2022. (NVIC Rapport 01/2022). Dutch.
  • Swedish Poisons Information Centre Annual Report 2021. Solna (Sweden): Giftinformationscentralen (Swedish Poisons Information Centre).
  • CIAV – Centro de Informação Antivenenos Dados Estatísticos 2021 [CIAV – Antivenom Information Center Statistical Data 2021]. Lisbon (Portugal): CIAV - Centro de Informação Antivenenos. Portugese.
  • Queensland Poisons Information Centre Annual Report 2019. South Brisbane (Australia): Queensland Poisons Information Centre.
  • Western Australian Poisons Information Centre Annual Report 2019. Perth (Australia): Western Australian Poisons Information Centre; 2020.
  • 2021 Top 10 Agents (In-Patients + Telephone Referrals) [Internet]. Philippines: National Poison Management and Control Center; 2022 [cited 2023 Jan 5]. Available from: https://www.facebook.com/photo/?fbid=464531358795251&set=a.354201129828275
  • Mainoli B, Gonçalves N, Ferreira JJ, et al. Potential drug-drug interactions in acute poisonings managed in the intensive care unit: occurrence, risk factors and relationship to patient severity on admission. Basic Clin Pharmacol Toxicol. 2022;130(2):337–345. doi: 10.1111/bcpt.13698
  • Siedler S, Trageser HB, Grensemann J, et al. Akute Intoxikationen auf der Intensivstation: eine 10-Jahres-Analyse [Acute intoxications in the intensive care unit: a 10-year analysis]. Med Klin Intensivmed Notfmed. 2022;117(2):129–136. German. doi: 10.1007/s00063-021-00839-8
  • Mehrpour O, Akbari A, Jahani F, et al. Epidemiological and clinical profiles of acute poisoning in patients admitted to the intensive care unit in eastern Iran (2010 to 2017). BMC Emerg Med. 2018;18(1):30. doi: 10.1186/s12873-018-0181-6
  • Gondim APS, Nogueira RR, Lima JGB, et al. Suicide attempts by exposure to toxic agents registered in a Toxicological Information and Assistance Center in Fortaleza, Ceará, Brazil, 2013. Epidemiol Serv Saude. 2017;26(1):109–119. doi: 10.5123/S1679-49742017000100012
  • Song SJ, Park GJ, Lee JH, et al. The Characteristics of Elderly Individuals Who Attempted Suicide by Poisoning: a Nationwide Cross-sectional Study in Korea. J Korean Med Sci. 2020;35(35):e286. doi: 10.3346/jkms.2020.35.e286
  • Sein Anand Ł, Sein Anand J. Self-poisonings before and during the initial year of the COVID-19 pandemic in northern Poland. Int J Occup Med Environ Health. 2022;35(5):527–535. doi: 10.13075/ijomeh.1896.01838
  • Knipe D, Silva T, Aroos A, et al. Hospital presentations for self-poisoning during COVID-19 in Sri Lanka: an interrupted time-series analysis. Lancet Psychiatry. 2021;8(10):892–900. doi: 10.1016/S2215-0366(21)00242-X
  • Beauchamp GA, Fishbein J, Makar GA, et al. Sex differences in patients with suicidal intent that are managed by toxicologists: an analysis of the Toxicology Investigators’ Consortium (ToxIC) Registry. Am J Emerg Med. 2020;38(2):333–338. doi: 10.1016/j.ajem.2019.158450
  • Canner JK, Giuliano K, Selvarajah S, et al. Emergency department visits for attempted suicide and self harm in the USA: 2006-2013. Epidemiol Psychiatr Sci. 2018;27(1):94–102. doi: 10.1017/S2045796016000871
  • Kumpula EK, Lambie B, Quigley P, et al. Prescribers aware: a cross-sectional study from New Zealand emergency departments on the substances used in intentional self-poisoning and their sources. J Prim Health Care. 2020;12(3):235–243. doi: 10.1071/HC20017
  • Laher AE, Motara F, Gihwala R, et al. The profile of patients presenting with intentional self-poisoning to the Charlotte Maxeke Johannesburg Academic Hospital emergency department, South Africa. S Afr Med J. 2022;112(5):347–351. doi: 10.7196/SAMJ.2022.v112i5.16366
  • Kumpula EK, Nada-Raja S, Norris P, et al. A descriptive study of intentional self-poisoning from New Zealand national registry data. Aust N Z J Public Health. 2017;41(5):535–540. doi: 10.1111/1753-6405.12702
  • Friðriksdóttir ÞA, Jónsdóttir F, Snook CP, et al. Paracetamol poisoning: a population-based study from Iceland. Scand J Gastroenterol. 2021;56(7):832–839. doi: 10.1080/00365521.2021.1921254
  • Popiolek I, Hydzik P, Jagielski P, et al. Risk Factors for Hepatotoxicity Due to Paracetamol Overdose in Adults. Medicina (Kaunas). 2021;57(8):752. doi: 10.3390/medicina57080752
  • Huang HS, Ho CH, Weng SF, et al. Long-term mortality of acetaminophen poisoning: a nationwide population-based cohort study with 10-year follow-up in Taiwan. Scand J Trauma Resusc Emerg Med. 2018;26(1):5. doi: 10.1186/s13049-017-0468-8
  • Chung YT, Chou CY, Tsai WC, et al. Acetaminophen Poisoning May Increase Coronary Artery Disease Risk: a Nationwide Cohort Study. Cardiovasc Toxicol. 2018;18(4):386–391. doi: 10.1007/s12012-017-9442-y
  • Mehrpour O, Saeedi F, Hoyte C. Decision tree outcome prediction of acute acetaminophen exposure in the United States: a study of 30,000 cases from the National Poison Data System. Basic Clin Pharmacol Toxicol. 2022;130(1):191–199. doi: 10.1111/bcpt.13674
  • Nash E, Sabih AH, Chetwood J, et al. Drug-induced liver injury in Australia, 2009-2020: the increasing proportion of non-paracetamol cases linked with herbal and dietary supplements. Med J Aust. 2021;215(6):261–268. doi: 10.5694/mja2.51173
  • Mallet M, Haq M, Tripon S, et al. Elevated procalcitonin is associated with bacterial infection during acute liver failure only when unrelated to acetaminophen intoxication. Eur J Gastroenterol Hepatol. 2017;29(7):811–816. doi: 10.1097/MEG.0000000000000862
  • Louvet A, Ntandja Wandji LC, Lemaître E, et al. Acute Liver Injury with Therapeutic Doses of Acetaminophen: a Prospective Study. Hepatology. 2021;73(5):1945–1955. doi: 10.1002/hep.31678
  • Moore JK, MacKinnon AC, Man TY, et al. Patients with the worst outcomes after paracetamol (acetaminophen)-induced liver failure have an early monocytopenia. Aliment Pharmacol Ther. 2017;45(3):443–454. doi: 10.1111/apt.13878
  • Spivak I, Arora J, Meinzer C, et al. Low Serum Hepcidin is Associated with Reduced Short-Term Survival in Adults with Acute Liver Failure. Hepatology. 2019;69(5):2136–2149. doi: 10.1002/hep.30486
  • Fontana RJ, Engle RE, Gottfried M, et al. Role of Hepatitis E Virus Infection in North American Patients with Severe Acute Liver Injury. Clin Transl Gastroenterol. 2020;11(11):e00273. doi: 10.14309/ctg.0000000000000273
  • Koch DG, Speiser JL, Durkalski V, et al. The Natural History of Severe Acute Liver Injury. Am J Gastroenterol. 2017;112(9):1389–1396. doi: 10.1038/ajg.2017.98
  • Stravitz RT, Fontana RJ, Meinzer C, et al. Coagulopathy, Bleeding Events, and Outcome According to Rotational Thromboelastometry in Patients with Acute Liver Injury/Failure. Hepatology. 2021;74(2):937–949. doi: 10.1002/hep.31767
  • Santos G, Figueira ERR, D’Albuquerque LAC, et al. Evaluation of drug-induced liver injury as etiology for acute liver failure in Brazil. Ann Hepatol. 2021;23:100310. doi: 10.1016/j.aohep.2021.100310
  • Liu Y, Zhan SP, Song L, et al. Drug-Induced Liver Injury: clinical and Etiologic Features at a Large Tertiary Teaching Hospital in China. Med Sci Monit. 2020;26:e919435. doi: 10.12659/MSM.919435
  • Zhang C, Wu Y, Yuan S, et al. Characteristics of Drug-Induced Liver Injury in Northeast China: disease Spectrum and Drug Types. Dig Dis Sci. 2020;65(11):3360–3368. doi: 10.1007/s10620-019-06030-6
  • Das S, Behera SK, Xavier AS, et al. Agreement Among Different Scales for Causality Assessment in Drug-Induced Liver Injury. Clin Drug Investig. 2018;38(3):211–218. doi: 10.1007/s40261-017-0601-5
  • Rathi C, Pipaliya N, Patel R, et al. Drug Induced Liver Injury at a Tertiary Hospital in India: etiology, Clinical Features and Predictors of Mortality. Ann Hepatol. 2017;16(3):442–450. doi: 10.5604/01.3001.0009.8600
  • Bourhia M, Ullah R, Alqahtani AS, et al. Evidence of drug-induced hepatotoxicity in the Maghrebian population. Drug Chem Toxicol. 2022;45(3):985–989. doi: 10.1080/01480545.2020.1797088
  • Abid A, Subhani F, Kayani F, et al. Drug induced liver injury is associated with high mortality—A study from a tertiary care hospital in Pakistan. PLoS ONE. 2020;15(4):e0231398. doi: 10.1371/journal.pone.0231398
  • Ortland I, Mirjalili M, Kullak-Ublick GA, et al. Drug-induced liver injury in Switzerland: an analysis of drug-related hepatic disorders in the WHO pharmacovigilance database VigiBase™ from 2010 to 2020. Swiss Med Wkly. 2021;151(1920):w20503. doi: 10.4414/smw.2021.20503
  • Yeboah-Korang A, Louissaint J, Tsung I, et al. Utility of a Computerized ICD-10 Algorithm to Identify Idiosyncratic Drug-Induced Liver Injury Cases in the Electronic Medical Record. Drug Saf. 2020;43(4):371–377. doi: 10.1007/s40264-019-00903-5
  • Yeboah-Korang A, Memon A, Patel N, et al. Impact of Prior Drug Allergies on the Risk, Clinical Features, and Outcomes of Idiosyncratic Drug-Induced Liver Injury in Adults. Dig Dis Sci. 2022;67(11):5262–5271. doi: 10.1007/s10620-022-07403-0
  • Louissaint J, Kassab I, Yeboah-Korang A, et al. Combining K-72 Hepatic Failure with 15 Individual T-Codes to Identify Patients with Idiosyncratic Drug-Induced Liver Injury in the Electronic Medical Record. Dig Dis Sci. 2022;67(8):4243–4249. doi: 10.1007/s10620-021-07223-8
  • Oliveira JdFMd, Wagner GA, Romano-Lieber NS, et al. Medicine poisoning mortality trend by gender and age group, São Paulo State, Brazil, 1996-2012. Cien Saude Colet. 2017;22(10):3381–3391. doi: 10.1590/1413-812320172210.12782017
  • Xiao L, Ye Y, Wang Y, et al. A 9-year retrospective study of poisoning-related deaths in Southwest China (Sichuan). Forensic Sci Int. 2021;318:110558. doi: 10.1016/j.forsciint.2020.110558
  • Koskela L, Raatiniemi L, Bakke HK, et al. Do pre-hospital poisoning deaths differ from in-hospital deaths? A retrospective analysis. Scand J Trauma Resusc Emerg Med. 2017;25(1):48. doi: 10.1186/s13049-017-0391-z
  • Gunnarsdottir OS, Rafnsson V. Accidental poisoning, intentional self-harm and event of undetermined intent mortality over 20 years in Iceland: a population-based cohort study. BMJ Open. 2020;10(5):e034590. doi: 10.1136/bmjopen-2019-034590
  • Lynn E, Cousins G, Lyons S, et al. Comparing characteristics of suicide to non-suicide drug poisoning deaths, by sex, in Ireland. J Affect Disord. 2022;306:80–89. doi: 10.1016/j.jad.2022.03.030
  • Magalhães AFA, Caldas ED. Underreporting of fatal poisonings in Brazil - a descriptive study using data from four information systems. Forensic Sci Int. 2018;287:136–141. doi: 10.1016/j.forsciint.2018.03.040
  • Koskela L, Raatiniemi L, Bakke HK, et al. Fatal poisonings in Northern Finland: causes, incidence, and rural-urban differences. Scand J Trauma Resusc Emerg Med. 2017;25(1):90. doi: 10.1186/s13049-017-0431-8
  • González-Santiago O, Morales-San Claudio PC, Cantú-Cárdenas LG, et al. Unintentional and self-poisoning mortalities in Mexico, 2000–2012. PLoS ONE. 2017;12(7):e0181708. doi: 10.1371/journal.pone.0181708
  • Gharbaoui M, Ben Khelil M, Harzallah H, et al. Pattern of suicide by self-poisoning in Northern Tunisia: an eleven-year study (2005-2015). J Forensic Leg Med. 2019;61:1–4. doi: 10.1016/j.jflm.2018.10.004
  • Schmidt LE, Rasmussen DN, Petersen TS, et al. Fewer adverse effects associated with a modified two-bag intravenous acetylcysteine protocol compared to traditional three-bag regimen in paracetamol overdose. Clin Toxicol (Phila). 2018;56(11):1128–1134. doi: 10.1080/15563650.2018.1475672
  • Wong A, Isbister G, McNulty R, et al. Efficacy of a two bag acetylcysteine regimen to treat paracetamol overdose (2NAC study). EClinicalMedicine. 2020;20:100288. doi: 10.1016/j.eclinm.2020.100288
  • Shoib S, Patel V, Khan S, et al. Over-the-counter drug use in suicidal/self-harm behavior: scoping review. Health Sci Rep. 2022;5(3):e662. doi: 10.1002/hsr2.662
  • Wazaify M, Kennedy S, Hughes CM, et al. Prevalence of over-the-counter drug-related overdoses at Accident and Emergency departments in Northern Ireland – a retrospective evaluation. J Clin Pharm Ther. 2005;30(1):39–44. doi: 10.1111/j.1365-2710.2004.00607.x
  • Morthorst BR, Erlangsen A, Nordentoft M, et al. Availability of Paracetamol Sold Over the Counter in Europe: a Descriptive Cross‐Sectional International Survey of Pack Size Restriction. Basic Clin Pharmacol Toxicol. 2018;122(6):643–649. doi: 10.1111/bcpt.12959
  • Gedeborg R, Svennblad B, Holm L, et al. Increased availability of paracetamol in Sweden and incidence of paracetamol poisoning: using laboratory data to increase validity of a population-based registry study. Pharmacoepidemiol Drug Saf. 2017;26(5):518–527. doi: 10.1002/pds.4166
  • Hopkins AG, Spiller HA, Kistamgari S, et al. Suicide-related over-the-counter analgesic exposures reported to United States poison control centers, 2000-2018. Pharmacoepidemiol Drug Saf. 2020;29(9):1011–1021. doi: 10.1002/pds.4997
  • Medicines Classification Database [Internet]. MEDSAFE: New Zealand medicines and medical devices safety authority; [Updated 2023 Jan 27; cited 2022 Dec 28]. Available from: https://www.medsafe.govt.nz/profs/class/classintro.asp.
  • Poisons Standard October 2022. Canberra. Standard No. 37. Australian Capital Territory (Australia): Department of Health and Aged Care; 2022.
  • Modified-release paracetamol-containing products to be suspended from EU market [Internet]. London (UK): European Medicines Agency; 2018 [cited 2023 Jan 19]. Available from: https://www.ema.europa.eu/en/medicines/human/referrals/paracetamol-modified-release
  • 1.4. Final decision in relation to paracetamol (modified release) [Internet]. Canberra (Australia): Department of Health and Aged Care (Therapeutic Goods Administration); 2019 [updated 2019 Aug 26; cited 2022 Aug 31]. Available from. https://www.tga.gov.au/resources/publication/scheduling-decisions-final/notice-final-decision-amend-or-not-amend-current-poisons-standard-august-2019/14-final-decision-relation-paracetamol-modified-release
  • Morgan O, Majeed A. Restricting paracetamol in the United Kingdom to reduce poisoning: a systematic review. J Public Health. 2005;27(1):12–18. doi: 10.1093/pubmed/fdh200
  • Turvill JL, Burroughs AK, Moore KP. Change in occurrence of paracetamol overdose in UK after introduction of blister packs. Lancet. 2000;355(9220):2048–2049. doi: 10.1016/S0140-6736(00)02355-2
  • Hawton K, Simkin S, Deeks J, et al. UK legislation on analgesic packs: before and after study of long term effect on poisonings. BMJ. 2004;329(7474):1076. doi: 10.1136/bmj.38253.572581.7C
  • Morgan O, Griffiths C, Majeed A. Impact of paracetamol pack size restrictions on poisoning from paracetamol in England and Wales: an observational study. J Public Health. 2005;27(1):19–24. doi: 10.1093/pubmed/fdh216
  • Morgan OW, Griffiths C, Majeed A, et al. Interrupted time-series analysis of regulations to reduce paracetamol (acetaminophen) poisoning. PLOS Med. 2007;4(4):e105. doi: 10.1371/journal.pmed.0040105
  • Bateman DN, Gorman DR, Bain M, et al. Legislation restricting paracetamol sales and patterns of self-harm and death from paracetamol-containing preparations in Scotland. Br J Clin Pharmacol. 2006;62(5):573–581. doi: 10.1111/j.1365-2125.2006.02668.x
  • Hawton K, Bergen H, Simkin S, et al. Long term effect of reduced pack sizes of paracetamol on poisoning deaths and liver transplant activity in England and Wales: interrupted time series analyses. BMJ. 2013;346():f403. doi: 10.1136/bmj.f403.
  • Greene SL, Dargan PI, Leman P, et al. Paracetamol availability and recent changes in paracetamol poisoning: is the 1998 legislation limiting availability of paracetamol being followed? Postgrad Med J. 2006;82(970):520–523. doi: 10.1136/pgmj.2005.042036
  • Molloy P, Chambers R, Cork T. How well are national guidelines relating to the general sales of aspirin and paracetamol, adhered to by retail stores: a mystery shopper study. BMJ Open. 2016;6(1):e010081. doi: 10.1136/bmjopen-2015-010081
  • Buckley NA, Gunnell D. Does restricting pack size of paracetamol (acetaminophen) reduce suicides? PLOS Med. 2007;4(4):e152. doi: 10.1371/journal.pmed.0040152
  • Morthorst BR, Erlangsen A, Chaine M, et al. Restriction of non-opioid analgesics sold over-the-counter in Denmark: a national study of impact on poisonings. J Affect Disord. 2020;268:61–68. doi: 10.1016/j.jad.2020.02.043
  • Steeg S, Carr MJ, Mok PLH, et al. Temporal trends in incidence of hospital-treated self-harm among adolescents in Denmark: national register-based study. Soc Psychiatry Psychiatr Epidemiol. 2020;55(4):415–421. doi: 10.1007/s00127-019-01794-8
  • Goldberger D, Vearrier D. Evaluation of a food and drug administration mandate to limit acetaminophen in prescription combination products. J Med Toxicol. 2017;13(4):303–308. doi: 10.1007/s13181-017-0622-8
  • Antoniou T, Guan Q, Martins D, et al. Impact of acetaminophen product labelling changes in Canada on hospital admissions for accidental acetaminophen overdose: a population-based study. CMAJ. 2022;194(15):E542–E548. doi: 10.1503/cmaj.210842
  • Cairns R, Noghrehchi F, Buckley NA. The impact on poisonings of up-scheduling of modified release paracetamol to Schedule 3 (pharmacist only medicine).Med J Aust. 2023;218(9):412–414. doi: https://doi.org/10.5694/mja2.51888
  • de Silva V, Ratnayake A. Increased use of medicinal drugs in self-harm in urban areas in Sri Lanka. Arch Suicide Res. 2008;12(4):366–369. doi: 10.1080/13811110802325265